Mecobalamin + Alpha Lipoic Acid + Pyridoxine Hydrochloride + Folic AcidThird Party Manufacturing in India

Mecobalamin + Alpha Lipoic Acid + Pyridoxine Hydrochloride + Folic Acid works through a multi-target nutritional approach to support nerve health, repair neuronal damage, and improve neuropathic symptoms. Mecobalamin, the active coenzyme form of vitamin B12, acts as an essential cofactor for methionine synthase, an enzyme that converts homocysteine to methionine, a precursor for S-adenosylmethionine which is critical for myelin sheath formation and maintenance. It also promotes nucleic acid synthesis and neuronal regeneration by accelerating axonal transport and synaptic transmission. Alpha lipoic acid functions as a potent mitochondrial antioxidant that scavenges reactive oxygen species and regenerates other endogenous antioxidants. It improves endothelial function and increases nitric oxide-mediated vasodilation, enhancing blood flow to peripheral nerves. Alpha lipoic acid also facilitates glucose uptake into cells, addressing the metabolic component of diabetic neuropathy. Pyridoxine hydrochloride, or vitamin B6, serves as a coenzyme in neurotransmitter biosynthesis, including serotonin and dopamine, and is essential for homocysteine metabolism. Folic acid provides the methyl donor pool necessary for DNA repair and cell division, further supporting homocysteine remethylation. Together, these four agents synergistically lower homocysteine levels, reduce oxidative stress in neural tissues, and promote remyelination, making this combination highly effective for diabetic and peripheral neuropathies.

Therapeutic Uses

This combination is prescribed for:

• Diabetic Peripheral Neuropathy: Alleviating pain, tingling, burning sensation, and numbness associated with diabetic nerve damage by improving nerve conduction velocity and reducing oxidative stress.
• Subacute Combined Degeneration of the Cord: Treating neurological manifestations of vitamin B12 and folate deficiency, including sensory ataxia and motor weakness.
• Peripheral Neuritis: Managing nerve inflammation caused by nutritional deficiencies, alcoholism, metabolic disorders, or drug-induced neuropathies.
• Homocysteine Regulation: Supporting the remethylation of homocysteine to methionine, thereby lowering elevated plasma homocysteine levels, a known cardiovascular and neurovascular risk factor.
• Adjuvant Therapy in Neuralgias: Providing nutritional support for conditions such as trigeminal neuralgia, post-herpetic neuralgia, and other chronic neuropathic pain syndromes.

Why Manufacturers Choose Mecobalamin Alpha Lipoic Acid Folic Acid

This combination addresses the rapidly growing market for neuropathic pain management, driven by the global rise in diabetes prevalence. Diabetic neuropathy affects approximately 50% of diabetic patients, creating a massive and expanding patient pool that requires long-term symptomatic and disease-modifying therapy. The multi-ingredient formulation provides a comprehensive therapeutic approach that no single-agent therapy can match, giving brands a distinct clinical advantage in the neuropathic segment. The combination is prescribed not only by endocrinologists and diabetologists but also by neurologists and general practitioners, broadening the prescriber base. Manufacturing this fixed-dose combination requires precise blending of four active ingredients at varying concentrations, ensuring content uniformity and stability. Indian WHO-GMP manufacturers offering this combination can capture both the domestic prescription market and high-volume export opportunities to regions with high diabetic populations, including Southeast Asia, the Middle East, Africa, and Latin America.

This makes Mecobalamin Alpha Lipoic Acid Folic Acid tablet one of the most sought-after neuropathic formulations for third party manufacturing in India.